Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
NMSC requires more aggressive screening, treatment, doctor says
Zurich - Although data on the incidence and prevalence of non-melanoma skin cancer (NMSC) remain limited, Dr. Rolf-Markus Szeimies of the department of dermatology, University of Regensburg Hospital, Germany, has compiled epidemiologic data demonstrating an increased incidence of actinic keratosis (AK), squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Related Content
